Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 19 Lung Neoplasms 18 Breast Neoplasms 12 Multiple Myeloma 10 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myeloid, Acute 8 Rectal Neoplasms 7 Carcinoma, Hepatocellular 7 Myelodysplastic Syndromes 6 Mouth Neoplasms 6 Sarcoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Pancreatic Neoplasms 5 Oropharyngeal Neoplasms 5 Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myelomonocytic, Chronic 5 Head and Neck Neoplasms 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Melanoma 4 Lymphoma, B-Cell 4 Leukemia, Biphenotypic, Acute 4 Glioma 4 Fallopian Tube Neoplasms 4 Uterine Cervical Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Lymphoma, T-Cell 3 Lymphoma, Non-Hodgkin 3 Laryngeal Neoplasms 3

Interventions

Surveys and Questionnaires 5 pazopanib 3 Erlotinib Hydrochloride 3 Cetuximab 3 Vorinostat 2 Oxaliplatin 2 Bevacizumab 2 Azacitidine 2 temsirolimus 1 satraplatin 1 ixazomib 1 X-Rays 1 Videotape Recording 1 Valproic Acid 1 Trastuzumab 1 Sugars 1 Sorafenib 1 Platinum 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Lenalidomide 1 Lapatinib 1 LY 2275796 1 Fluorouracil 1 Everolimus 1 Curcumin 1 Crizotinib 1 Capecitabine 1 Asian ginseng 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Cancers × X-Rays × Clear all

NCT01432119 2013-04-09

Phase 1 Trial With SIR-Spheres and Cetuximab +/- Erlotinib

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡